News: Achievement

23 March 2022

Dexa Group's High TKDN Products Become Pharmaceutical Products in Business Matching

Dexa Group is one of the pharmaceutical companies that take part in Business Matching activities organized by the Ministry of Industry to maximize the purchase of domestic products. The event, which took place on the 22nd until 24th of March 2022 in Nusa Dua, Bali, continued the Bangga Buatan Indonesia…
4 June 2021

Dexa Medica Launches Konos: Double Attack Agains Cold and Cough

Dexa Medica, a leading multinational pharmaceutical company in Indonesia through its Nigerian distribution partner Orange Drugs Ltd launches a very effective and highly recommended cold and cough brand named Konos. Konos, aimed at providing relief from cold and cough disturbing and interrupting the daily lives and activities of Nigerians. At…
11 May 2021

Increasingly Global, OMAI HerbaKOF Enters Nigerian Market with the Name HerbaCough

Dexa Medica made a breakthrough in Nigeria by launching the country's first herbal cough medicine, HerbaCough. According to the Country Manager of Dexa Medica Nigeria and West Africa, Mr. Dhanang Anggoro, so far in the country there have been many cough medicines made from chemicals. "Currently, there are many chemical…
13 April 2021

Indonesia Indigenous Modern Medicine from Dexa Group is increasingly known to the world through Hannover Messe 2021

Indonesia is the Official Partner Country in the 2021 Hannover Messe. During the 72 years of holding the Hannover Messe, the health sector appeared for the first time this year and Dexa Group took part. Dexa Group carries the proud product of the innovation of the nation's children, Indonesia Indigenous…
1 April 2021

Stimuno Receives Indonesia Best Pharmacy Brand Award 2021

Over the last 17 years, based on the Marketing Authorization Number (NIE) registered in the National Agency of Drugs and Food Control (BPOM), Indonesia records 23 traditional medicines classified as phytopharmaceuticals. Stimuno has been one of the first phytopharmaceuticals in the country since 2005. Being the authentic Indonesian immunomodulatory product…
10 November 2020

Dexa Medica Granted Highest Award for Innovation, President Jokowi: Indonesia Needs Health Innovators

Dexa Group, through PT Dexa Medica, won the 2020 Innovative Industry Award from the Ministry of Research and Technology/National Research and Innovation Agency (Kemenristek/BRIN). The award was given for Dexa Group’s commitment to developing Native Indonesian Modern Medicine (OMAI). The 2020 Innovative Industry Award was opened with remarks from President…
25 May 2020

STIMUNO Wins 11th Top Brand Award

STIMUNO received another Top Brand Award 2020 for 11 consecutive years. Launched in 1999, the brand has achieved numerous awards and achievements during its 20-year journey as an immunomodulator in Indonesia, as reported in Marketing Magazine 06/XX/June 2020. Commercial Director of PT Dexa Medica, V. Hery Sutanto said that STIMUNO…
25 May 2020

DLBS Executive Director Listed as SINTA 2020 Best Researcher

Executive Director of Dexa Laboratories of Biomolecular Sciences (DLBS), Dr. Raymond R. Tjandrawinata has been named the Best Researcher in the Science and Technology Index (SINTA) 2020 by scoring very high cumulative Google Scholar H-index. The total number of researchers who work as lecturers and are registered at SINTA is…
10 December 2019

Indonesia IndigenousModern Medicine, Redacid Obtained Phytopharmaceutical NIE

Indonesia Indigenous Modern Medicine (OMAI) from Dexa Group, REDACID obtained its Marketing Authorization Number (NIE) as a phytopharmaceutical product from the National Agency of Drug and Food Control (BPOM). This product license is in line with BPOM’s efforts to support the downstreaming of drugs and food research and development through…
4 December 2019

Government Appreciates Dexa Group Research and Development

The Ministry of Research and Technology of the Republic of Indonesia appreciates Dexa Group through PT Dexa Medica as an industry that contributes to research and development activities to produce pharmaceutical products that have competitive advantage and innovation. Minister of Research and Technology (Menristek) / Head of the Research and…